Guidance on intensive care for COVID-19 in HIV


  • Jo Whelan
  • Medical News
Access to the full content of this site is available only to registered healthcare professionals. Access to the full content of this site is available only to registered healthcare professionals.

Recommendations from the Intensive Care Society and the British HIV Association aim to support appropriate decision-making around escalation of care for people with HIV and safe maintenance of HIV therapy, including common pitfalls.

The statement notes, among other points:

  • There are important issues related to antiretroviral therapy (ART) for acutely unwell patients with HIV.
  • HIV testing is an important part of the diagnostic work-up for people admitted with acute respiratory illness.
  • Patients with well controlled HIV have similar intensive care outcomes to HIV-negative individuals, and HIV is not a predictor of mortality in people with acute lung injury admitted to intensive care.
  • Well-controlled HIV should not be included as a prognostic indicator when assessing appropriateness for escalation of care.

The statement gives a 7-point summary followed by 8 recommendations, and can be found at https://www.bhiva.org/BHIVA-statement-on-considerations-for-critical-care-for-people-with-HIV-during-COVID-19